Chemtura beats estimates, but bromine weakness persists
21:49 PM | July 30, 2013 | Vincent Valk
Chemtura's second-quarter net income from continuing declined 11% year-on-year (YOY), to $47 million, or 47 cts/share, on sales down 1%, to $735 million, the company says. Adjusted net income declined...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.